## Is ADM's OvoPro Deal the Inflection Point for Fermentation-Derived Egg Proteins?

**Orders for Every's OvoPro in the first four months of 2026 were 550% of the company's total 2024 volume** — a demand signal that pushed startup Every to partner with ingredients giant ADM for scaled precision fermentation manufacturing. The collaboration, announced July 16, gives food companies access to a vegan, cholesterol-free egg protein with a protein digestibility corrected amino acid score (PDCAAS) of 1.0, the highest possible quality ranking. OvoPro delivers the binding, gelling, foaming, and whipping functionality that has made egg proteins irreplaceable in food formulation — and does so without exposure to the avian influenza-driven price swings that sent egg costs to record highs in 2025.

The deal pairs Every's fermentation-derived protein biology with ADM's existing precision fermentation infrastructure, positioning the partnership as a direct supply-chain hedge for food manufacturers burned by egg market volatility. Every also recently announced a separate manufacturing expansion with partner Huvepharma to quadruple production capacity, signaling that the company is betting heavily on parallel scale-up pathways rather than a single manufacturing dependency.

---

## Why Egg Protein Is a Harder Problem Than It Looks

Egg proteins are notoriously difficult to replicate functionally. The PDCAAS of 1.0 is table stakes — whey also hits that ceiling — but eggs earn their formulation premium through a combination of thermal gelation, emulsification, and foaming properties that most plant-based alternatives approximate poorly. Starch-based egg replacers from companies like Ardent Mills (which offers its Egg Replace product for baked goods) reduce egg content but typically require reformulation compromises.

OvoPro claims to be the first egg alternative produced through [precision fermentation](https://synbiointel.com/glossary/biosynthetic-pathway), meaning the functional proteins are expressed in a microbial host rather than extracted from plants or synthesized chemically. This matters for formulation: fermentation-derived proteins can, in principle, retain the precise structural conformations that drive the functional properties food scientists depend on. Whether OvoPro's fermentation-expressed proteins match native egg white proteins across all processing conditions — pasteurization temperatures, freeze-thaw cycles, low-pH beverage matrices — is not addressed in the source material and remains an open technical question for industrial buyers.

---

## ADM's Precision Fermentation Play

ADM's involvement is strategically significant beyond this single product. The company is positioning its precision fermentation capabilities as a platform service for ingredient innovation — a model that mirrors what contract development and manufacturing organizations ([CDMOs](https://synbiointel.com/glossary/cdmo)) have done in the pharmaceutical sector. Kris Lutt, ADM's vice president for innovation and growth, framed the deal in supply-chain terms: "We're strengthening the global protein supply chain while demonstrating how ADM's industry-leading precision fermentation capabilities can complement existing production, expand supply and help customers innovate."

That framing is telling. ADM is not presenting this as an alt-protein ideological bet but as an infrastructure and supply diversification argument — a pitch more likely to land with procurement teams at major food manufacturers than with ESG-focused investors alone.

OvoPro's application scope, as described in source material, spans frozen foods, sweet baked goods, pastas, and beverages — a broad surface area that also puts it in direct competition with whey protein concentrate in fortified food and beverage applications, where whey prices have surged on protein fortification demand.

---

## Skeptical Take: Scale Is Still the Central Question

The 550% order growth figure is striking, but it describes demand relative to a small 2025 baseline — the absolute volumes are not disclosed. Precision fermentation remains one of the more capital-intensive routes to commodity-scale protein production. [Bioreactor](https://synbiointel.com/glossary/bioreactor) yields, downstream processing costs, and the economics of achieving cost parity with conventional egg white protein at industrial volumes are the metrics that will determine whether this partnership translates into durable market share or remains a premium niche.

The dual manufacturing strategy — ADM on one track, Huvepharma on another — suggests Every is aware of this constraint and is hedging against single-point bottlenecks. It also raises questions about IP and supply exclusivity that the available source material does not resolve.

Ardent Mills and other incumbent egg-alternative suppliers are unlikely to cede ground without reformulation investment of their own. And conventional egg prices, while still below their 2025 peaks according to the source, have historically recovered from HPAI-driven spikes — reducing the urgency premium that precision fermentation alternatives currently enjoy.

---

## Industry Trajectory

This deal is part of a broader pattern: large agricultural ingredients companies acquiring or partnering with fermentation startups to de-risk their protein portfolios against commodity volatility. The strategic logic is sound. Precision fermentation-derived proteins offer supply predictability that commodity agriculture cannot — provided the fermentation economics reach cost competitiveness. ADM's scale and fermentation infrastructure could accelerate that curve for Every faster than a standalone startup path would allow.

For synbio platform builders, the more interesting signal is that fermentation-derived functional food proteins — not just nutritional ones — are now attracting Tier 1 ingredient company partnerships. Functionality, not just amino acid profile, is becoming the commercial differentiation axis.

---

## Key Takeaways

- **Every's OvoPro orders in the first four months of 2026 were 550% of the company's entire 2025 volume**, indicating rapid demand acceleration.
- **OvoPro carries a PDCAAS of 1.0** and delivers egg-like binding, gelling, foaming, and whipping functionality — claims that incumbent egg replacers have not fully matched.
- **ADM will scale OvoPro through its precision fermentation capabilities**, positioning itself as a platform fermentation provider for food ingredient innovation.
- **Every is running parallel manufacturing expansion** with Huvepharma to quadruple production, alongside the ADM deal — a dual-track scale strategy.
- **Egg prices remain below their 2025 records** but avian influenza volatility continues to drive ingredient buyers toward supply-stable alternatives.
- **Absolute production volumes and fermentation economics are not disclosed**, leaving cost competitiveness with conventional egg protein an open question.

---

## Frequently Asked Questions

**What is OvoPro and who makes it?**
OvoPro is an egg protein ingredient produced by startup Every through precision fermentation. It is vegan, cholesterol-free, and claims a PDCAAS of 1.0. Every recently partnered with ADM to scale production.

**How does precision fermentation differ from plant-based egg alternatives?**
Precision fermentation uses engineered microbial hosts to express specific proteins — in this case, egg proteins — rather than extracting proteins from plants. This approach can, in principle, replicate the structural and functional properties of native egg proteins more closely than plant-derived starches or legume proteins.

**Why is ADM partnering with Every rather than developing its own egg protein?**
ADM is positioning its precision fermentation infrastructure as a scale-up platform for third-party ingredient developers. Partnering with Every allows ADM to commercialize existing fermentation capacity while Every contributes the proprietary protein biology and market traction.

**What drove the surge in OvoPro demand in early 2026?**
The source cites continued avian influenza-driven egg price volatility and the broader trend of food companies seeking stable-supply, lower-cost alternatives to conventional eggs. Egg prices reached record highs in 2025 before declining.

**Is OvoPro cost-competitive with conventional egg white protein?**
The source does not disclose pricing or fermentation cost data. Cost competitiveness at industrial scale remains the central unresolved question for precision fermentation-derived food proteins broadly.